US Codex
C.F.R.
Browse by date
Notes

§516.155. Labeling of indexed drugs.

21 C.F.R. § 516.155

(a)
The labeling of an indexed drug that is found to be eligible for indexing under § 516.129(c)(7)(i) shall state, prominently and conspicuously: “LEGAL STATUS—In order to be legally marketed, a new animal drug intended for a minor species must be Approved, Conditionally Approved, or Indexed by the Food and Drug Administration. THIS PRODUCT IS INDEXED—MIF # (followed by the applicable minor species index file number and a period).” “Extra-label use is prohibited.” “This product is not to be used in animals intended for use as food for humans or food-producing animals.”
(b)
The labeling of an indexed drug that is found to be eligible for indexing for use in an early, non-food life stage of a food-producing minor species animal, under § 516.129(c)(7)(ii), shall state, prominently and conspicuously: “LEGAL STATUS—In order to be legally marketed, a new animal drug intended for a minor species must be Approved, Conditionally Approved, or Indexed by the Food and Drug Administration. THIS PRODUCT IS INDEXED—MIF # (followed by the applicable minor species index file number and a period).” “Extra-label use is prohibited.”
(c)
The labeling of an indexed drug shall contain such other information as may be prescribed in the index listing.
Notes, amendments, and revision history

Amendments

[72 FR 69121, Dec. 6, 2007, as amended at 89 FR 42362, May 15, 2024]

Source

Source: 72 FR 69121, Dec. 6, 2007, unless otherwise noted.

Authority

Authority: 21 U.S.C. 360ccc-1, 360ccc-2, 371.

Source

Source: 72 FR 41017, July 26, 2007, unless otherwise noted.

Amendments

[72 FR 69121, Dec. 6, 2007, as amended at 89 FR 42362, May 15, 2024]